HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
ALS-08
Description
ALS-08 is a proprietary creatine-derivative that is being developed as a potential therapeutic for amyotrophic lateral sclerosis (ALS). It is being developed by Avicena Group, Inc.
No brand information found.
